JPMORGAN CHASE &

Thoma Bravo explores $7B sale of Imprivata, turning $544M into 13x return. Healthcare cybersecurity M&A heats up as AI drives security spending.

Thoma Bravo Eyes $7 Billion Exit From Healthcare Cybersecurity Bet Imprivata

Goldman Sachs BDC

UBS Group

Indonesia's IDX CEO and financial regulator resign after $80B market crash. MSCI threatens frontier downgrade over transparency concerns. What it means for EM investors.

Indonesia Market Chiefs Resign After $80 Billion Meltdown as MSCI Threatens Frontier Downgrade

AMAZON COM

SpaceX reveals $8B profit on $15-16B revenue in 2025. Banks estimate $1.5T+ IPO valuation—potentially the largest tech offering ever.

SpaceX Posts $8 Billion Profit as Banks Eye $1.5 Trillion IPO Valuation

Under Armour

Prem Watsa's Fairfax Financial amasses $204M in Under Armour stock—a 22% stake. Why Canada's top value investor is betting on Kevin Plank's turnaround.

The Canadian Warren Buffett Just Bet $204 Million on Under Armour's Comeback

Walt Disney

Disney's board to name Iger's successor within days. Parks chief Josh D'Amaro emerges as front-runner with 86% prediction market odds.

Disney Board Set to Choose Iger's Successor Within Days

Spero Therapeutics

Spero Therapeutics founder Ankit Mahadevia resigns from board just two weeks after paying $112,500 SEC penalty. End of a 12-year era.

News

Yesterday

Thoma Bravo Eyes $7 Billion Exit From Healthcare Cybersecurity Bet Imprivata

Indonesia Market Chiefs Resign After $80 Billion Meltdown as MSCI Threatens Frontier Downgrade

SpaceX Posts $8 Billion Profit as Banks Eye $1.5 Trillion IPO Valuation

The Canadian Warren Buffett Just Bet $204 Million on Under Armour's Comeback

Disney Board Set to Choose Iger's Successor Within Days

Spero Founder Exits Board Two Weeks After SEC Settlement